Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis
- PMID: 1916049
- DOI: 10.1007/BF00403280
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis
Abstract
According to recent prospective studies, hypofibrinolysis due to elevated plasma plasminogen activator inhibitor 1 levels appears to be an independent risk factor for myocardial reinfarction in men, and hyperinsulinaemia, a major indicator of insulin resistance is considered as a risk factor for coronary disease. It has recently been shown that insulin resistance is accompanied by an increased plasma plasminogen activator inhibitor 1 concentration: A significant correlation coefficient was demonstrated between plasminogen activator inhibitor 1 and fasting plasma insulin in the normal population, in obese subjects, in Type 2 (non-insulin-dependent) diabetic patients and in angina pectoris. Attempts to decrease insulin resistance such as fasting, diet, or administration of an oral anti-diabetic drug such as Metformin induced a parallel decrease in plasma insulin and plasminogen activator inhibitor 1 levels. This inhibitor is produced by endothelial cells and by hepatocytes in culture. Plasminogen activator inhibitor 1 synthesis by hepatocytes in culture was stimulated by an increasing insulin concentration, or low density lipoproteins, whereas the endothelial cell synthesis was stimulated by very low density lipoproteins especially when they were obtained from hypertriglyceridaemic patients. Therefore, a direct effect of insulin or lipoprotein changes on the cells which synthesize plasminogen activator inhibitor 1 could be responsible for its increased plasma concentration in insulin resistance states. The increase in plasma plasminogen activator inhibitor 1 levels linked to hyperinsulinaemia is a tempting partial explanation for the association between insulin resistance and coronary disease.
Similar articles
-
Hypofibrinolysis and insulin-resistance.Diabete Metab. 1991 May;17(1 Pt 2):96-100. Diabete Metab. 1991. PMID: 1936490
-
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.Dan Med Bull. 2002 Feb;49(1):43-60. Dan Med Bull. 2002. PMID: 11894723 Review.
-
Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.Diabetologia. 1993 Sep;36(9):817-25. doi: 10.1007/BF00400356. Diabetologia. 1993. PMID: 8104834
-
Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.Diabetes. 2000 Apr;49(4):633-9. doi: 10.2337/diabetes.49.4.633. Diabetes. 2000. PMID: 10871202
-
[Fibrinolytic system and hyperinsulinism].Journ Annu Diabetol Hotel Dieu. 1990:181-91. Journ Annu Diabetol Hotel Dieu. 1990. PMID: 2114499 Review. French. No abstract available.
Cited by
-
Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.Can J Cardiol. 2016 Oct;32(10 Suppl 2):S349-S357. doi: 10.1016/j.cjca.2016.07.507. Epub 2016 Jul 22. Can J Cardiol. 2016. PMID: 27692115 Free PMC article. Review.
-
Regulation of plasminogen activation on cell surfaces and fibrin.J Thromb Haemost. 2018 May 20;16(8):1487-97. doi: 10.1111/jth.14157. Online ahead of print. J Thromb Haemost. 2018. PMID: 29779246 Free PMC article. Review.
-
Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.Diabetes Obes Metab. 2023 Feb;25(2):570-580. doi: 10.1111/dom.14903. Epub 2022 Nov 10. Diabetes Obes Metab. 2023. PMID: 36306151 Free PMC article. Clinical Trial.
-
Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis.Diabetes Care. 2009 Feb;32(2):361-6. doi: 10.2337/dc08-0854. Epub 2008 Nov 18. Diabetes Care. 2009. PMID: 19017770 Free PMC article.
-
Association between Diastolic Dysfunction with Inflammation and Oxidative Stress in Females ob/ob Mice.Front Physiol. 2017 Aug 23;8:572. doi: 10.3389/fphys.2017.00572. eCollection 2017. Front Physiol. 2017. PMID: 28878683 Free PMC article.